Nephrogen

Updated: October 29, 2025
CEO - Demetri Maxim
CEO - Demetri Maxim
Country: USA | Funding: $20K (+)

Website: https://www.nephrogenbiotech.com

Nephrogen is a biotech company developing curative gene therapies for kidney diseases.

Competitors